Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Study of N91115 in Patients With CF Homozygous for the F508del-CFTR Mutation
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of N91115 to Evaluate Efficacy and Safety in Patients With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation Treated With Lumacaftor/Ivacaftor
Status: Enrolling
Updated:  7/27/2016
Medical Center of Wisconsin
mi
from
Madison, WI
Study of N91115 in Patients With CF Homozygous for the F508del-CFTR Mutation
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of N91115 to Evaluate Efficacy and Safety in Patients With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation Treated With Lumacaftor/Ivacaftor
Status: Enrolling
Updated: 7/27/2016
Medical Center of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Antagonism of Opioid-Induced Respiratory Depression by CX1739 With Preservation of Opioid Analgesia
Antagonism of Opioid-Induced Respiratory Depression by CX1739 With Preservation of Opioid Analgesia
Status: Enrolling
Updated:  7/27/2016
Duke Clinical Research Unit
mi
from
Durham, NC
Antagonism of Opioid-Induced Respiratory Depression by CX1739 With Preservation of Opioid Analgesia
Antagonism of Opioid-Induced Respiratory Depression by CX1739 With Preservation of Opioid Analgesia
Status: Enrolling
Updated: 7/27/2016
Duke Clinical Research Unit
mi
from
Durham, NC
Click here to add this to my saved trials
Intervening to Improve Infant Health in Ghana
Intervening to Improve Birth Weight and Infant Respiratory Health in Rural Ghana
Status: Enrolling
Updated:  7/28/2016
Columbia University Medical Center
mi
from
New York, NY
Intervening to Improve Infant Health in Ghana
Intervening to Improve Birth Weight and Infant Respiratory Health in Rural Ghana
Status: Enrolling
Updated: 7/28/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Intervening to Improve Infant Health in Ghana
Intervening to Improve Birth Weight and Infant Respiratory Health in Rural Ghana
Status: Enrolling
Updated:  7/28/2016
Kintampo Medical Research Center
mi
from
Kintampo,
Intervening to Improve Infant Health in Ghana
Intervening to Improve Birth Weight and Infant Respiratory Health in Rural Ghana
Status: Enrolling
Updated: 7/28/2016
Kintampo Medical Research Center
mi
from
Kintampo,
Click here to add this to my saved trials
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Status: Enrolling
Updated:  7/28/2016
University of Arizona College of Medicine
mi
from
Tucson, AZ
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Status: Enrolling
Updated: 7/28/2016
University of Arizona College of Medicine
mi
from
Tucson, AZ
Click here to add this to my saved trials
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Status: Enrolling
Updated:  7/28/2016
UCSD School of Medicine
mi
from
LaJolla, CA
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Status: Enrolling
Updated: 7/28/2016
UCSD School of Medicine
mi
from
LaJolla, CA
Click here to add this to my saved trials
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Status: Enrolling
Updated:  7/28/2016
National Jewish Medical and Research Center
mi
from
Denver, CO
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Status: Enrolling
Updated: 7/28/2016
National Jewish Medical and Research Center
mi
from
Denver, CO
Click here to add this to my saved trials
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Status: Enrolling
Updated:  7/28/2016
Washington University School of Medicine Patient Oriented Research Unit
mi
from
St. Louis, MO
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Status: Enrolling
Updated: 7/28/2016
Washington University School of Medicine Patient Oriented Research Unit
mi
from
St. Louis, MO
Click here to add this to my saved trials
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Status: Enrolling
Updated:  7/28/2016
Dept. of Health Evaluation Sciences, Penn State College of Medicine
mi
from
Hershey, PA
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Status: Enrolling
Updated: 7/28/2016
Dept. of Health Evaluation Sciences, Penn State College of Medicine
mi
from
Hershey, PA
Click here to add this to my saved trials
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Status: Enrolling
Updated:  7/28/2016
University of Wisconsin-Madison
mi
from
Madison, WI
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
Status: Enrolling
Updated: 7/28/2016
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Treatment of Persistent Wheezing in Infants and Children
Respiratory Function in Infants With Persistent Wheezing
Status: Enrolling
Updated:  7/28/2016
University of Michigan
mi
from
Ann Arbor, MI
Treatment of Persistent Wheezing in Infants and Children
Respiratory Function in Infants With Persistent Wheezing
Status: Enrolling
Updated: 7/28/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
Sildenafil Treatment in Patients With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension - a Pilot Cross-over Study
Status: Enrolling
Updated:  7/28/2016
UCLA Pulmonary Outpatient Clinic
mi
from
Los Angeles, CA
Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
Sildenafil Treatment in Patients With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension - a Pilot Cross-over Study
Status: Enrolling
Updated: 7/28/2016
UCLA Pulmonary Outpatient Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Comparison of Two Programs to Encourage Physical Activity in Individuals With Chronic Obstructive Pulmonary Disease
Exercise and Disability in COPD Patients
Status: Enrolling
Updated:  7/28/2016
Wake Forest University
mi
from
Winston-Salem, NC
Comparison of Two Programs to Encourage Physical Activity in Individuals With Chronic Obstructive Pulmonary Disease
Exercise and Disability in COPD Patients
Status: Enrolling
Updated: 7/28/2016
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Possible Relation of Toll-Like Receptors and Nitric Oxide to Chronic Lung Disease
TLR's, Nitric Oxide and Chronic Lung Disease: Any Connections?
Status: Enrolling
Updated:  7/28/2016
Children's Mercy Hospital & Clinic
mi
from
Kansas City, MO
Possible Relation of Toll-Like Receptors and Nitric Oxide to Chronic Lung Disease
TLR's, Nitric Oxide and Chronic Lung Disease: Any Connections?
Status: Enrolling
Updated: 7/28/2016
Children's Mercy Hospital & Clinic
mi
from
Kansas City, MO
Click here to add this to my saved trials
Possible Relation of Toll-Like Receptors and Nitric Oxide to Chronic Lung Disease
TLR's, Nitric Oxide and Chronic Lung Disease: Any Connections?
Status: Enrolling
Updated:  7/28/2016
Children's Hospital and Regional Medical Center - Seattle
mi
from
Seattle, WA
Possible Relation of Toll-Like Receptors and Nitric Oxide to Chronic Lung Disease
TLR's, Nitric Oxide and Chronic Lung Disease: Any Connections?
Status: Enrolling
Updated: 7/28/2016
Children's Hospital and Regional Medical Center - Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Interstitial Lung Diseases in the Veterans Administration
Interstitial Lung Diseases in the Veterans Administration Health System - A Retrospective Description of Patient Characteristics, Management, and Outcomes
Status: Enrolling
Updated:  8/1/2016
Durham VA Medical Center
mi
from
Durham, NC
Interstitial Lung Diseases in the Veterans Administration
Interstitial Lung Diseases in the Veterans Administration Health System - A Retrospective Description of Patient Characteristics, Management, and Outcomes
Status: Enrolling
Updated: 8/1/2016
Durham VA Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Birmingham, AL
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Los Angeles, CA
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
San Diego, CA
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Torrance, CA
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Denver, CO
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Chicago, IL
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Detroit, MI
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Omaha, NE
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Philadelphia, PA
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Spartanburg, SC
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Spartanburg, SC
Click here to add this to my saved trials
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Houston, TX
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated:  8/1/2016
mi
from
Pleven,
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Status: Enrolling
Updated: 8/1/2016
mi
from
Pleven,
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Univ of Florida Dept of Medicine
mi
from
Gainesville, FL
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Univ of Florida Dept of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
University of Miami Adult CF Center
mi
from
Miami, FL
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
University of Miami Adult CF Center
mi
from
Miami, FL
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Central Florida Pulmonary Group, PA
mi
from
Orlando, FL
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Central Florida Pulmonary Group, PA
mi
from
Orlando, FL
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
New Lung Associates
mi
from
Tampa, FL
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
New Lung Associates
mi
from
Tampa, FL
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Chicago Cystic Fibrosis INstitute
mi
from
Glenview, IL
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Chicago Cystic Fibrosis INstitute
mi
from
Glenview, IL
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Tulane University Health Sciences Center
mi
from
New Orleans, LA
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Tulane University Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Maine Medical Center
mi
from
Portland, ME
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Maine Medical Center
mi
from
Portland, ME
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Johns Hopkins University
mi
from
Baltimore, MD
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Wayne State University - Harper University Hospital
mi
from
Detroit, MI
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Wayne State University - Harper University Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Washington University
mi
from
St. Louis, MO
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Rutgets-Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Rutgets-Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Pediatric Pulmonology/Cystic Fibrosis
mi
from
Somerville, NJ
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Pediatric Pulmonology/Cystic Fibrosis
mi
from
Somerville, NJ
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Albany Medical College
mi
from
Albany, NY
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Clinical Research of Charlotte
mi
from
Charlotte, NC
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Clinical Research of Charlotte
mi
from
Charlotte, NC
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Toledo Hospital
mi
from
Toledo, OH
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Toledo Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials